Shuttle Pharmaceuticals Financials - Benzinga

Shuttle Pharmaceuticals Holdings Inc

SHPHNASDAQ

Trade with Public

Trade with Public

$4.09

0.5013.93%

가까이에: Sep 23, 5:00 PM EST

$4.00

0.4111.42%

프리마켓: 6:13 AM EST

실적: Q2 2026 실적이 목 9월 24th에 정규 거래 중 발표되었습니다.

개요 뉴스 실적 전망 이벤트재무심리 지분 현황 비교 주식 보고서

Shuttle Pharmaceuticals Financials

Shuttle Pharmaceuticals (SHPH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Shuttle Pharmaceuticals Q2 EPS $(3.10) Up From $(32.90) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.10) per share. This is a 90.58 percent increase over losses of $(32.90) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q1 EPS $(0.43) Up From $(7.60) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(0.43) per share. This is a 94.34 percent increase over losses of $(7.60) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q3 EPS $(1.05) Up From $(39.75) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.05) per share. This is a 97.36 percent increase over losses of $(39.75) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q2 EPS $(3.29) Up From $(24.12) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.29) per share. This is a 86.36 percent increase over losses of $(24.12) per share from the same period last year.

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals FY24 EPS $(3.30) Vs $(3.53) YoY

Benzinga Newsdesk

PRO
Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.59) per share. This is a 74.73 percent decrease over losses of $(0.91) per share from the same period last year.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved